Oncology | |||
Name | CAS Number | Application | Stage |
Abiraterone | 154229-19-3 | Prostate cancer | A |
Carfilzomib | 868540-17-4 | Multiple myeloma | A |
Ceritinib | 1032900-25-6 | Non-small cell lung cancer | A |
Ibrutinib | 936563-96-1 | Chronic lymphocytic leukaemia, MALT lymphoma, Mantle-cell lymphoma, Waldenstrom's macroglobulinaemia | A |
Idelalisib | 870281-82-6 | Chronic lymphocytic leukaemia, Follicular lymphoma | B |
Nintedanib | 656247-18-6 | Idiopathic pulmonary fibrosis, Non-small cell lung cancer | B |
Olaparib | 763113-22-0 | Ovarian cancer | A |
Osimertinib (AZD9291) | 1421373-65-0 | Non-small cell lung cancer | A |
Palbociclib | 571190-30-2 | Breast cancer | A |
Pralatrexate | 146464-95-1 | Peripheral T cell lymphoma | A |
Ribociclib | 1211441-98-3 | Breast cancer | C |
Tipiracil HCl | 183204-72-0 | Rectal cancer | A |
Venetoclax | 1257044-40-8 | Chronic lymphocytic leukaemia | C |
Diabetes | |||
Name | CAS Number | Application | Stage |
Canagliflozin | 842133-18-0 | Type 2 diabetes mellitus | A |
Dapagliflozin | 461432-26-8 | Type 2 diabetes mellitus | A |
Linagliptin | 668270-12-0 | Type 2 diabetes mellitus | A |
Omarigliptin | 1226781-44-7 | Type 2 diabetes mellitus | A |
Sitagliptin | 486460-32-6 | Type 2 diabetes mellitus | A |
Teneligliptin | 760937-92-6 | Type 2 diabetes mellitus | A |
Trelagliptin | 865759-25-7 | Type 2 diabetes mellitus | B |
HCV | |||
Name | CAS Number | Application | Stage |
Elbasvir | 1370468-36-2 | HCV | B |
Ledipasvir | 1256388-51-8 | HCV | A |
Sofosbuvir | 1190307-88-0 | HCV | A |
Telaprevir | 402957-28-2 | HCV | A |
Velpatasvir | 1377049-84-7 | HCV | B |
Favipiravir | 259793-96-9 | Influenza virus infections | B |
Cardio Cerebral Vascular | |||
Name | CAS Number | Application | Stage |
Anacetrapib | 875446-37-0 | Hypercholesterolemia | B |
Apixaban | 503612-47-3 | Venous Thromboembolism(VTE) | A |
Bosentan Hydrate | 157212-55-0 | Pulmonary arterial hypertension; Skin ulcer | A |
Dronedarone | 141626-36-0 | Atrial fibrillation, Atrial flutter | A |
Macitentan | 441798-33-0 | Pulmonary arterial hypertension | B |
Rivaroxaban | 366789-02-8 | Venous Thromboembolism(VTE) | A |
Selexipag | 475086-01-2 | Pulmonary arterial hypertension | B |
Ticagrelor | 274693-27-5 | Acute coronary syndromes | A |
LCZ696 Valsartan/Sacubitril (1:1) | 936623-90-4 | Heart Failure | A |
Nervous System | |||
Name | CAS Number | Application | Stage |
Asenapine | 65576-45-6 | Bipolar disorders, Schizophrenia | A |
Brivaracetam | 357336-20-0 | Epilepsy | A |
Eletriptan | 177834-92-3 | Menstrual migraine, Migraine | A |
Lacosamide | 175481-36-4 | Partial epilepsies | B |
Ramelteon | 196597-26-9 | Insomnia | A |
Rotigotine | 125572-93-2 | Parkinson's disease, Restless legs syndrome | A |
Suvorexant | 1030377-33-3 | Insomnia | B |
Vilazodone | 163521-12-8 | Major depressive disorder | A |
Vortioxetine | 960203-27-4 | Major depressive disorder | B |
Anti-infection | |||
Name | CAS Number | Application | Stage |
Avibactam | 1192500-31-4 | cIAI/cUTI | B |
Isavuconazole | 241479-67-4 | Antifungal | B |
Posaconazole | 171228-49-2 | Antifungal | A |
Tedizolid | 856866-72-3 | Skin and soft tissue infections | C |
Voriconazole | 137234-62-9 | Antifungal | A |
Immune System | |||
Name | CAS Number | Application | Stage |
Apremilast | 608141-41-9 | Plaque psoriasis, Psoriatic arthritis | C |
Bazedoxifene | 198481-33-3 | Postmenopausal osteoporosis | B |
Odanacatib | 603139-19-1 | Osteoporosis | A |
Tofacitinib | 477600-75-2 | Rheumatoid arthritis | A |
Others | |||
Name | CAS Number | Application | Stage |
Bedaquiline | 843663-66-1 | Tuberculosis | A |
Cinacalcet | 226256-56-0 | Hypercalcaemia; Primary hyperparathyroidism; Secondary hyperparathyroidism | A |
Darifenacin | 133099-04-4 | Overactive bladder | A |
Eluxadoline | 864821-90-9 | Irritable bowel syndrome | A |
Fesoterodine | 286930-02-7 | Overactive bladder | A |
Silodosin | 160970-64-9 | Benign prostatic hyperplasia | A |
Trifluridine | 70-00-8 | Eye infection | A |
Varenicline | 249296-44-4 | Smoking withdrawal | B |
Zilpaterol | 119520-06-8 | Asthma | A |
Tildipirosin | 328898-40-4 | Antibiotic (veterinary drug) | A |
Linezolid | 165800-03-3 | Anti-inflammatory | A |
Zopiclone | 43200-80-2 | Cardiovascular | A |
Cefuroxime | 55268-75-2 | Anti-inflammatory | A |
Cefodizime sodium | 86329-79-5 | Anti-inflammatory | A |
Cefoxitin sodium | 33564-30-6 | Anti-inflammatory | A |
Cefminox | 75481-73-1 | Anti-inflammatory | A |
Cefozopran HCl | 113981-44-5 | Anti-inflammatory | A |
Rabeprazole sodium | 117976-90-6 | Respiratory | A |
Fexofenadine | 83799-24-0 | Respiratory | A |
Tamsulosin hydrochloride | 106463-17-6 | Urinary system | A |
Raloxifene | 84449-90-1 | Cardiovascular | A |
Ganciclovir | 82410-32-0 | Anti-tumor | A |
Mycophenolate mofetil | 128794-94-5 | An immunosuppressant. | A |
Propiverine hydrochloride | 54556-98-8 | urinary incontinence | A |
Rocuronium bromide | 119302-91-9 | competitive neuromuscular blocker | A |
Atorvastatin Calcium | 134523-03-8 | competitive HMG-CoA reductase | A |
Rosuvastatin Calcium | 147098-20-2 | selective, competitive HMG-CoA reductase inhibitor,Antilipemic | A |
Vitamin D Drugs | |||
Name | CAS Number | Application | Stage |
1α,25-OH Vitamin D2 | 60133-18-8 | Hyperparathyroidism | A |
25-OH Vitamin D2 | 21343-40-8 | Hyperparathyroidism, Renal failure | A |
Alfacalcidol | 41294-56-8 | Hyperparathyroidism, Rickets, Osteoporosis | A |
Calcifediol | 63283-36-3 | Hypoparathyroidism, Rickets, Osteoporosis | A |
Calcipotriol | 112965-21-6 | Psoriasis | A |
Calcitriol | 32222-06-3 | Hypoparathyroidism, Chronic renal dialysis, Osteoporosis | A |
Doxercalciferol | 54573-75-0 | Secondary hyperparathyroidism, Metabolic bone disease | A |
Eldecalcitol | 104121-92-8 | Osteoporosis | B |
Falecalcitriol | 83805-11-2 | Hyperparathyroidism, Osteoporosis | B |
Maxacalcitol | 103909-75-7 | Hyperparathyroidism, Psoriasis | A |
Paricalcitol | 131918-61-1 | Secondary hyperparathyroidism | A |
Seocalcitol | 134404-52-7 | Anti tumor, Immune inhibitors | B |
Tacalcitol | 57333-96-7 | Psoriasis, Vitiligo | A |